10:24 AM EST - Axcan Pharma Inc. : grew its fourth-quarter revenue by 7.9 percent to US$72.3 million but saw its profit for the period fall to US$8.3 million due to the impact of discontinuing one of its programs. Axcan Pharma Inc. Axcan Pharma Inc.
shares T.AXP are trading unchanged at $16.93.
